ArticleBritish journal of cancer2020

CB11, a novel purine-based PPARɣ ligand, overcomes radio-resistance by regulating ATM signalling and EMT in human non-small-cell lung cancer cells.

Tae Woo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.